FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. The company was founded in 2003 and is headquartered in Montclair, New Jersey.
Frequently asked questions
What sector does Fluoropharma Medical (FPMI) operate in?
Fluoropharma Medical belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Fluoropharma Medical (FPMI) current stock price?
As of the latest data, Fluoropharma Medical stock price is $0.00, with a previous close of $0.00.
What is Fluoropharma Medical (FPMI) current market capitalization?
Fluoropharma Medical market cap is approximately 6.85 thousand.
Does Fluoropharma Medical (FPMI) pay dividends?
No. Fluoropharma Medical does not pay a dividend.
What is Fluoropharma Medical (FPMI) beta (volatility) score?
Fluoropharma Medical has a beta of -109.722, indicating lower volatility than the overall market.